Shumsheer Sidhu

Shumsheer Sidhu discloses dealings in Med BioGene Inc. to SEDI. In total, 2 filings cover trades dated 31 December 2015.

The open-market record is one-sided, with 2 purchases worth €1,043 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2016 alone, the filings show 2 purchases and no sales.

The latest filing, published on 20 January 2016, reports an open-market purchase of €179 in Med BioGene Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.